Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

Chung, Kenny K.K., Zhang, Yi, Lim, Kah Leong, Tanaka, Yuji, Huang, Hui, Gao, Jun, Ross, Christopher A., Dawson, Valina L. +1 more·2001·Nature Medicine
DOI 10.1038/nm1001-1144

Cited by (744)

Items 501–600 of 744

  1. Increased E4 Activity in Mice Leads to Ubiquitin-containing Aggregates and Degeneration of Hypothalamic Neurons Resulting in Obesity
    Etsuo A. Susaki, Chie Kaneko-Oshikawa, Keishi Miyata, Mitsuhisa Tabata, Tetsuya Yamada, Yuichi Oike, Hideki Katagiri, Keiichi I. Nakayama · 2010 · Journal of Biological Chemistry
  2. Parkin and 𝛂-Synuclein: Opponent Actions in The Pathogenesis of Parkinson’S Disease
    Melisa J. Baptista, Mark Cookson, David W. Miller · 2004 · The Neuroscientist
  3. Parkin increases the risk of colitis by downregulation of VDR via autophagy-lysosome degradation
    Zemeng Ma, Junxian Wu, Yuqing Wu, Xiaomeng Sun, Zebing Rao, Naishuang Sun, Yu Fu, Zaikui Zhang, Jingzhou Li, Mengjun Xiao et al. · 2023 · International Journal of Biological Sciences
  4. Parkin promotes proteasomal degradation of synaptotagmin IV by accelerating polyubiquitination
    Hiroyuki Kabayama, Naoko Tokushige, Makoto Takeuchi, Miyuki Kabayama, Mitsunori Fukuda, Katsuhiko Mikoshiba · 2017 · Molecular and Cellular Neuroscience
  5. Olfaction in Parkin carriers in Chinese patients with Parkinson disease
    Ying Wang, Jian‐Jun Wu, Fengtao Liu, Kui Chen, Chen Chen, Su‐Shan Luo, Yixuan Wang, Dake Li, Rong‐Yuan Guan, Yujie Yang et al. · 2017 · Brain and Behavior
  6. EGFR trafficking: parkin' in a jam
    Koraljka Husnjak, Ivan Đikić · 2006 · Nature Cell Biology
  7. Plasma-Enabled Carbon Nanostructures for Early Diagnosis of Neurodegenerative Diseases
    Shafique Pineda, Zhaojun Han, Kostya Ostrikov · 2014 · Materials
  8. Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies – synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions
    Eizo Iseki, Noriko Takayama, Yoshiko Furukawa, Wami Marui, Toshiki Nakai, Satoshi Miura, Kenji Uéda, Kenji Kosaka · 2002 · Neuroscience Letters
  9. Hypocretin (Orexin) Replacement Therapies
    Erica M. Seigneur, Luı́s de Lecea · 2020 · Medicine in Drug Discovery
  10. MS-based glycomics: An analytical tool to assess nervous system diseases
    Wenjing Peng, Firas H. Kobeissy, Stefania Mondello, Chloe Barsa, Yehia S. Mechref · 2022 · Frontiers in Neuroscience
  11. Identification of Parkinson’s disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson’s disease patients
    Rowena J. Keyser, Ekow Oppon, Jonathan Ambrose Carr, Soraya Bardien · 2011 · Journal of Neural Transmission
  12. Etiopatogenia da Doença de Parkinson
    Hélio AG Teive · 2019 · Revista Neurociências
  13. Spectrum of phenotypes and genotypes in Parkinson's disease
    Olaf Rieß, Rejko Krüger, Jörg Bernhard Schulz · 2002 · Journal of Neurology
  14. Synphilin-1 Interacts with AMPK and Increases AMPK Phosphorylation
    Tianxia Li, Jingnan Liu, Gongbo Guo, Bo Ning, Xueping Li, Guangjing Zhu, Dejun Yang, Timothy H. Moran, Wanli W. Smith · 2020 · International Journal of Molecular Sciences
  15. Diminution of eIF4E activity suppresses parkin mutant phenotypes
    Cristina Ottone, Alessia Galasso, Marica Gemei, Viviana Pisa, Silvia Gigliotti, Federica Piccioni, Franco Graziani, Arturo C. Verrotti · 2010 · Gene
  16. The Guanine Nucleotide Exchange Factor Kalirin-7 Is a Novel Synphilin-1 Interacting Protein and Modifies Synphilin-1 Aggregate Transport and Formation
    Yu-Chun Tsai, Olaf Rieß, Anne S. Soehn, Huu Phuc Nguyen · 2012 · PLoS ONE
  17. Effect of Schiff base Cu(II) complexes on signaling pathways in HT-29 cells
    Katarína Koňariková, Georgios A. Perdikaris, Helena Gbelcová, Lucia Andrezálová, Martin Švéda, Tomáš Ruml, Lucia Laubertová, Ingrid Žitňanová · 2016 · Molecular Medicine Reports
  18. Parkinsonism
    Wolfgang Hermann Oertel, Stanley Fahn · 2003 · Elsevier eBooks
  19. Significance of the parkin gene and protein in understanding Parkinson’s disease
    Paul S. Fishman, George A. Oyler · 2002 · Current Neurology and Neuroscience Reports
  20. Case‐control study of the α‐synuclein interacting protein gene and Parkinson's disease
    Demetrius M. Maraganore, Matthew James Farrer, Timothy G. Lesnick, Mariza de Andrade, James H. Bower, Dena G. Hernandez, John Hardy, Walter A. Rocca · 2003 · Movement Disorders
  21. Phase contrast radiography of Lewy bodies in Parkinson disease
    Seong‐Beom Koh, Sang‐il Suh, D. H. Lee, A. R. Kim, Chil Hwan Oh, J.S. Yoon, Byung Mook Weon, Seung Kwon Seol, Ahram Pyun, Jung Ho Je et al. · 2006 · NeuroImage
  22. The Role of Rab Proteins in Mitophagy: Insights into Neurodegenerative Diseases
    Adeena Shafique, Martina Brughera, Marta Lualdi, Tiziana Alberio · 2023 · International Journal of Molecular Sciences
  23. Can parkin be a target for future treatment of Parkinson's disease?
    Shinichiro Kubo, Taku Hatano, Masashi Takanashi, Nobutaka Hattori · 2013 · Expert Opinion on Therapeutic Targets
  24. Parkinson’s Protein α-Synuclein Binds Efficiently and with a Novel Conformation to Two Natural Membrane Mimics
    Pravin Kumar, Ine M. J. Segers‐Nolten, Nathalie Schilderink, Vinod Subramaniam, Martina Huber · 2015 · PLoS ONE
  25. Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
    Anne‐Sophie Van Rompuy, Marusela Oliveras-Salvá, Anke Van der Perren, Olga Corti, Chris Van den Haute, Veerle Baekelandt · 2015 · Molecular Neurodegeneration
  26. The C-terminus of PARK2 is required for its self-interaction, solubility and role in the spindle assembly checkpoint
    Yvan Chen, Shang-Ting Fang, Pei-Chi Yeh, Hsueh‐Hui Yang, Shin-Yuan Chen, Chih-Jui Chang, Wei‐Jun Zhai, Yi Cheng Chen, Yue‐Li Juang · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  27. Overexpression of Septin 4, the Drosophila homologue of human CDCrel‐1, is toxic for dopaminergic neurons
    Verónica Francisca Loewe Muñoz, Nuria Paricio · 2007 · European Journal of Neuroscience
  28. Synphilin-1 Binds ATP and Regulates Intracellular Energy Status
    Tianxia Li, Jingnan Liu, Wanli W. Smith · 2014 · PLoS ONE
  29. Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson’s disease
    Thomas Franck, Rejko Krüger, Dirk Woitalla, Thomas H. Müller, Simone Engelender, Olaf Rieß · 2006 · Journal of Neural Transmission
  30. Screening for mutations in synaptotagmin XI in Parkinson’s disease
    Anne S. Glass, D. P. Huynh, Th. Franck, Dirk Woitalla, Th. Müller, Stefan M. Pulst, Daniela Berg, Rejko Krüger, Olaf Rieß · 2004 · Journal of neural transmission. Supplementum
  31. A-Syn(ful) MAM: A Fresh Perspective on a Converging Domain in Parkinson’s Disease
    Peter A. Barbuti · 2024 · International Journal of Molecular Sciences
  32. iPS models of Parkin and PINK1
    Aleksandar Raković, Philip Seibler, Christine Klein · 2015 · Biochemical Society Transactions
  33. Isolated RING2 Domain of Parkin Is Sufficient for E2-Dependent E3 Ligase Activity
    Carolyn A. Rankin, Nadezhda A. Galeva, KyeongMin Bae, Mirza Nayyar Ahmad, Travis M. Witte, Mark L. Richter · 2013 · Biochemistry
  34. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells
    Andreas Koch, Klaus Lehmann‐Horn, Justus C. Dächsel, Thomas Gasser, Philipp J. Kahle, Christoph B. Lücking · 2008 · Parkinsonism & Related Disorders
  35. The Ataxia-ome: Connecting Disease Proteins of the Cerebellum
    Sandrine Humbert, Frédéric Saudou · 2006 · Cell
  36. Parkin: clinical aspects and neurobiology
    Yi Zhang, Valina Lynn Dawson, Ted M. Dawson · 2001 · Clinical Neuroscience Research
  37. Unaltered α-synuclein blood levels in juvenile Parkinsonism with a parkin exon 4 deletion
    David W. Miller, Anthony Crawley, Katrina A. Gwinn, Grisel J. Lopez, Robert Luke Nussbaum, Mark Cookson, Andrew Singleton, John Hardy, Okan Doğu · 2004 · Neuroscience Letters
  38. Identification and Molecular Characterization of Parkin in Clonorchis sinensis
    Xuelian Bai, Tae‐im Kim, Ji-Yun Lee, Fuhong Dai, Sung‐Jong Hong · 2015 · Korean Journal of Parasitology
  39. Therapeutic potential of Parkin and its regulation in Parkinson’s disease
    Narukkottil Safreena, Indu C. Nair, Goutam Chandra · 2024 · Biochemical Pharmacology
  40. Membrane Binding of Parkinson's Protein α‐Synuclein: Effect of Phosphorylation at Positions 87 and 129 by the S to D Mutation Approach
    Pravin Kumar, Nathalie Schilderink, Vinod Subramaniam, Martina Huber · 2016 · Israel Journal of Chemistry
  41. PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ
    Sangram Nag, Mahabuba Jahan, Miklós Tóth, Ryuji Nakao, Andrea Varrone, Christer Halldin · 2021 · ACS Chemical Neuroscience
  42. Anticipatory Postural Adjustments and Compensatory Postural Responses to Multidirectional Perturbations—Effects of Medication and Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease
    Tobias Heß, Christian Oehlwein, Thomas L. Milani · 2023 · Brain Sciences
  43. Regulation of tyrosine hydroxylase: relevance to Parkinson's disease
    Gelareh Alam, Jason R. Richardson · 2020 · Elsevier eBooks
  44. Parkin occurs in a stable, non‐covalent, ∼110‐kDa complex in brain
    Cindy Van Humbeeck, Etienne Waelkens, Olga Corti, Alexis Brice, Wim Vandenberghe · 2008 · European Journal of Neuroscience
  45. Sequence conservation between mouse and human synphilin-1
    Casey O’Farrell, Fiona Pickford, Liselot Vink, Eileen M. McGowan, Mark Cookson · 2002 · Neuroscience Letters
  46. Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators
    Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang · 2023 · Molecules
  47. VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
    Xi Chen, Elpida Tsika, Nathan D. Levine, Darren J. Moore · 2023 · Molecular Neurodegeneration
  48. A meta‐analysis of the relationship of the Parkin p.Val380Leu polymorphism to Parkinson's disease
    Yi Zhang, Zhen‐Zhen Wang, Hong‐Mei Sun · 2013 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  49. Parkinson's genetics—creating exciting new insights
    D.A. Grimes, Dennis E. Bulman · 2002 · Parkinsonism & Related Disorders
  50. Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-parkinson's disease agent, after oral administration in rats and dogs
    Jong‐Woo Jeong, Changsun Yu, Jong‐Hwa Lee, Kyoung‐Sik Moon, Eunhee Kim, Sung‐Eun Yoo, Tae‐Sung Koo · 2016 · Regulatory Toxicology and Pharmacology
  51. Juvenile parkinsonism
    Ergun Y. Uc, Robert L. Rodnitzky · 2003 · Seminars in Pediatric Neurology
  52. Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
    Jaimin Patel, Nikhil Panicker, Valina Lynn Dawson, Ted M. Dawson · 2022 · CNS Drugs
  53. Of Parkin and Parkinson's: light and dark sides of a multifaceted E3 ubiquitin–protein ligase
    Olga Corti, Alexis Brice · 2007 · Drug Discovery Today Disease Mechanisms
  54. The identification of dysfunctional crosstalk of pathways in Parkinson disease
    Hongyu Diao, Xinxing Li, Sheng Hu · 2012 · Gene
  55. A novel role for parkin in trauma-induced central nervous system secondary injury
    Karim Mukhida, N.R. Kobayashi, I. Méndez · 2005 · Medical Hypotheses
  56. Naturally- and experimentally-designed restorations of the Parkin gene deficit in autosomal recessive juvenile parkinsonism
    Hirohide Asai, Makito Hirano, Takao Kiriyama, Masanori Ikeda, Satoshi Ueno · 2009 · Biochemical and Biophysical Research Communications
  57. Genetic causes of Parkinson’s disease: extending the pathway
    Olaf Rieß, Rejko Krüger, Helmine Hochstrasser, Anne S. Soehn, Silke Nuber, Thomas Franck, Daniela Berg · 2006 · Springer eBooks
  58. Tumor necrosis factor receptor-associated factor 6 interaction with alpha-synuclein enhances cell death through the Nuclear Factor-kB pathway
    Lidia Yshii, Adriana Oliveira Manfiolli, Alexandre Denadai‐Souza, Paula Fernanda Kinoshita, Marcelo D. Gomes, Cristóforo Scavone · 2020 · IBRO Reports
  59. Presence of β-arrestin in cellular inclusions in metamphetamine-treated PC12 cells
    Antonio De Blasi, Loredana Capobianco, Luisa Iacovelli, Paola Lenzi, Michela Ferrucci, Gloria Lazzeri, Francesco Fornai, Antonietta Picascia · 2003 · Neurological Sciences
  60. More than 20 years of the discovery of Park2
    Yoshikuni Mizuno · 2020 · Neuroscience Research
  61. Glycogen synthase kinase‐3β phosphorylates synphilin‐1 in vitro
    Kunikazu Tanji, Tsutomu Toki, Wakako Tamo, Tadaatsu Imaizumi, Tomoh Matsumiya, Fumiaki Mori, Hitoshi Takahashi, Kei Satoh, Koichi Wakabayashi · 2003 · Neuropathology
  62. Genetics of Parkinson's Disease
    Yue Ming Huang, Piu Chan, Glenda Margaret Halliday · 2007 · Elsevier eBooks
  63. Evaluation of PARKIN gene variants in West Bengal Parkinson’s disease patients
    Jaya Sanyal, Arpita Jana, Epsita Ghosh, Tapas Kumar Banerjee, Durga Prasad Chakraborty, Vadlamudi Raghavendra Rao · 2015 · Journal of Human Genetics
  64. Advances in genetic models of Parkinson's disease
    Michael K. Lee, Donald L. Price · 2001 · Clinical Neuroscience Research
  65. ISG15‐dependent Regulation
    Arthur L. Haas · 2007 · Wiley eBooks
  66. Zebrafish-Based Parkinson's Disease Models: Unveiling Genetic Mechanisms and Therapeutic Pathways
    Rohinee Dodiya, Pratishtha Sharma, Dipa K. Israni, Mohammad Amjad Kamal, Nigel H. Greig · 2025 · CNS & Neurological Disorders - Drug Targets
  67. Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson’s Disease Pathogenesis
    Xuanxiang Jin, Xiaoli Si, Xiaoguang Lei, Huifang Liu, Anwen Shao, Lingfei Li · 2023 · Aging and Disease
  68. Neurotrophic Natural Products
    Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada · 2024 · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products
  69. Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W
    Bernardo A. Bustillos, Liam T. Cocker, Matt Coban, Caleb A. Weber, Jenny M. Bredenberg, Paige K Boneski, Joanna S. Siuda, Jarosław W. Sławek, Andreas Puschmann, Derek P. Narendra et al. · 2024 · Cells
  70. The Role of the Ubiquitination Machinery in Dislocation and Degradation of Endoplasmic Reticulum Proteins
    Marjolein Kikkert, Gerco C. Hassink, Emmanuel J. H. J. Wiertz · 2006 · Springer eBooks
  71. The Hsp70 Chaperone System in Parkinson’s Disease
    Adahir Labrador‐Garrido, Carlos W., Cintia Roodveldt · 2011 · InTech eBooks
  72. Parkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in α-synuclein transgenic mice
    Margot Fournier, Amandine Roux, Jérôme Garrigue, Marie‐Paule Muriel, Paul Blanche, Hilal Ahmed Lashuel, John P Anderson, Robin Barbour, Jiping Huang, Sophie Tézenas du Montcel et al. · 2013 · BMC Neuroscience
  73. Molecular Chaperones and the Ubiquitin–Proteasome System
    Cam Patterson, Jörg Höhfeld · 2007 · Wiley eBooks
  74. Mitochondrial Injury: A Hot Spot for Parkinsonism and Parkinson's Disease?
    Benoit I. Giasson · 2004 · Science of Aging Knowledge Environment
  75. α-Synuclein Drives SNARE-Dependent Tubular Remodeling of Vesicles
    Qun Li, Tao Hu, Li Fan, Yutong Xing, Zhenyong Wu · 2025 · Journal of the American Chemical Society
  76. α-synuclein pathogenesis in hiPSC models of Parkinson’s disease
    Jara M. Baena-Montes, Sahar Avazzadeh, Leo R. Quinlan · 2021 · Neuronal Signaling
  77. Symptomatology and Clinical Features of Parkinson's Disease
    Abdelaati El Khiat, Bilal El‐Mansoury, Driss Ait Ali, Mohamed El Koutbi, Kamal Kaoutar, Youssef Ait Hamdan, Brahim El Houate, Lahcen Tamegart, Kamal Smimih, Adnane Hakam et al. · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  78. Drosophila melanogaster Parkin ubiquitinates peanut and septin1 as an E3 ubiquitin–protein ligase
    Young-Joo Bae, Soon-Ja Kang, Kwang Sook Park · 2007 · Insect Biochemistry and Molecular Biology
  79. Pathogenesis of Parkinson's Disease
    Amitabh Gupta, Ted M. Dawson · 2009 · Blue books of neurology
  80. Fas‐associated factor 1 induces the accumulation of α‐synuclein through autophagic suppression in dopaminergic neurons
    Bok‐Seok Kim, Taeik Jang, Sung‐Eun Yoo, Jae Moon Lee, Eunhee Kim · 2021 · The FASEB Journal
  81. Lack of direct role of parkin in the steady-state level and aggregation of α-synuclein and the clearance of pre-formed aggregates
    Yoon Suk Kim, Smita S. Patel, Seung‐Jae Lee · 2005 · Experimental Neurology
  82. Synphilin-1 regulates mechanotransduction in rigidity sensing through interaction with zyxin
    Seok Gi Kim, Jinyan Li, Ji Su Hwang, Mohamed F. Y. Hassan, Ye Eun Sim, Ju Yeon Lee, Jung‐Soon Mo, Myeong Ok Kim, Gwang Lee, Sungsu Park · 2025 · Journal of Nanobiotechnology
  83. Progress of non‐motor symptoms in early‐onset Parkinson's disease
    Fanshi Zhang, Ai‐Di Luo, Shusheng Liao, Mei Liu, Jun Zhang, Zucai Xu · 2024 · Ibrain
  84. Increased synphilin-1 expression in human elderly brains with substantia nigra Marinesco bodies.
    Anna Krygowska‐Wajs, Tomasz Lenda, Dariusz Adamek, Marek M Moskała, Katarzyna Z. Kuter, Jerzy Kunz, Maria Śmiałowska, Krystyna Ossowska · 2008 · PubMed
  85. SAR study of niclosamide derivatives for neuroprotective function in SH-SY5Y neuroblastoma
    Shizue Mito, Benxu Cheng, Benjamin Aaron Garcia, Xin Yee Ooi, Daniela Gonzalez, Tess C. Ruiz, Francisco X. Elisarraras, Andrew T. C. Tsin · 2023 · Bioorganic & Medicinal Chemistry Letters
  86. Behavioral Characterization of the Hyperphagia Synphilin-1 Overexpressing Mice
    Xueping Li, Yada Treesukosol, Alexander A. Moghadam, Megan Smith, Erica M. Ofeldt, Dejun Yang, Tianxia Li, Kellie L. Tamashiro, Pique P. Choi, Timothy H. Moran et al. · 2014 · PLoS ONE
  87. Aberrant Nitric Oxide Signaling Contributes to Protein Misfolding in Neurodegenerative Diseases via S-Nitrosylation and Tyrosine Nitration
    Tomohiro Nakamura, Stuart A. Lipton · 2017 · Elsevier eBooks
  88. Does Impaired Plantar Cutaneous Vibration Perception Contribute to Axial Motor Symptoms in Parkinson’s Disease? Effects of Medication and Subthalamic Nucleus Deep Brain Stimulation
    Tobias Heß, Peter Themann, Christian Oehlwein, Thomas L. Milani · 2023 · Brain Sciences
  89. Nonenzymatic Posttranslational Protein Modifications: Mechanism and Associated Disease Pathologies
    Sheeza Khan, Ajaz Ahmad Bhat · 2019 · Elsevier eBooks
  90. Role of Genes and Treatments for Parkinson’s Disease
    Falaq Naz, Yasir Hasan Siddique · 2020 · The Open Biology Journal
  91. Curcuma longa extract ameliorates motor and cognitive deficits of 6-hydroxydopamine-infused Parkinson’s disease model rats
    Sujan Bhowmick, Marzan Sarkar, Jakir Hussain, Mehedi Hassan, Mafroz Ahmed Basunia, Taslima Nahar, Md. Azizur Rahman, Borhan Uddin, Shahdat Hossain · 2021 · Oriental Pharmacy and Experimental Medicine
  92. Efficacy and safety of botulinum toxin for treating motor dysfunction in patients with Parkinson’s disease: a systematic review and meta-analysis
    Yuqi Yang, Tong Zhang, Lixu Liu, Lei Shan, Xueyan Hu, Lingyu Yang, Fei Gao, Xiaoli Wu, Hanzhi Li · 2023 · BMJ Open
  93. Parkinsonism proteolysis and proteasomes
    Lawrence M. Schwartz, John R. Nambu, Zhongde Wang · 2002 · Cell Death and Differentiation
  94. Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons
    Sissel Ida Schmidt, Justyna Okarmus, Daniel Aghaie Madsen, Julie Schmidt Hansen, Emil Gregersen, Hjalte Gram, Lucas Seidelin Winkelmann, Anderson Souza Oliveira, Rachel Heon‐Roberts, Brent James Ryan et al. · 2025 · npj Parkinson s Disease
  95. An update on the monogenic causes of Parkinson’s disease: Impact on patient stratification and personalised medicine
    Sakeena Asmi, Anand Krishnan, Sneha Mary Alexander, Jimna Mohamed Ameer, T. Nidhish, Sen Chandra Sreetama, Keerthi Tr, Rajesh Anantha Shenoi, S G S Chakravarthy, Goutam Chandra · 2026 · Ageing Research Reviews
  96. Genetics of Parkinson disease
    Nathan Pankratz, Tatiana Foroud · 2004 · Neurotherapeutics
  97. Bone Quality in Patients with Parkinson’s Disease Determined by Quantitative Ultrasound (QUS) of the Calcaneus: Influence of Sex Differences
    Jordi Caplliure‐Llopis, Dolores Escrivá, Esther Navarro-Illana, María Benlloch, José Enrique de la Rubia Ortí, Carlos Barrios · 2022 · International Journal of Environmental Research and Public Health
  98. Dynamic Role of Ubiquitination in the Management of Misfolded Proteins Associated with Neurodegenerative Diseases
    Esther S.P. Wong, Jeanne M.M. Tan, Kah‐Leong Lim · 2008 · Focus on structural biology
  99. Neuroscience at Johns Hopkins
    Solomon H. Snyder · 2005 · Neuron
  100. Chapter 8 α-Synuclein and Synucleinopathies
    Michael G. Schlossmacher · 2007 · Blue books of neurology